| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/28/2006 | CA2386793C New selective retinoid agonists |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2290392C Salts of optically active sulfoxide derivative |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031191A1 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 03/23/2006 | WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | WO2006030285A1 New 1,2,4-triazole-3-carboxamide derivatives |
| 03/23/2006 | WO2006030221A1 Pharmaceutical composition comprising a betaminetic agent and a mucolytic agent |
| 03/23/2006 | WO2006029981A1 Abin-mediated protection against lung inflammatory disease |
| 03/23/2006 | WO2006029685A1 Barn dust extract providing protection from allergies |
| 03/23/2006 | WO2005120148A3 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 03/23/2006 | WO2005048985A3 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 03/23/2006 | WO2005046658A3 Methods of modulating angiogenesis and cancer cell proliferation |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | CA2580717A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580107A1 Growth factor treatment for asthma |
| 03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/22/2006 | EP1637589A1 Novel stem cell derived from adult tissue and use thereof |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637159A1 Immunocompetent cell activation inhibitor and use thereof |
| 03/22/2006 | EP1637148A1 Novel therapeutic use of polypodium extracts |
| 03/22/2006 | EP1637147A1 Stable dust extract for allergy protection |
| 03/22/2006 | EP1637128A2 Use of simple amino acids to form porous particles |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636221A2 New azetidine compounds |
| 03/22/2006 | EP1636211A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1636210A1 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents |
| 03/22/2006 | EP1635844A1 Salmeterol and ciclesonide combination |
| 03/22/2006 | EP1635834A2 Novel compounds |
| 03/22/2006 | EP1635819A1 Staurosporine derivatives for hypereosinophilic syndrome |
| 03/22/2006 | EP1635811A2 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 03/22/2006 | EP1635798A2 Inhibitors of histone deacetylases for the suppression therapy of diseases |
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1294353B1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1212089B1 Synergistic combination of roflumilast and salmeterol |
| 03/22/2006 | EP1207867B1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 03/22/2006 | EP1179008B1 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1749277A Heat shock protein 65-human SARS coronary virus epitope antigen recombinant fusion protein (HSP65SARS/3CL161-264) |
| 03/22/2006 | CN1749257A Platelet activation factor resisting compound |
| 03/22/2006 | CN1748786A Lactic streptostacin lozenge and its preparing method |
| 03/22/2006 | CN1748754A Chinese medicine dripping pill for treating upper respiratory tract disease |
| 03/22/2006 | CN1748748A Little leaf deervetch herb preparation for pregnant woman and new preparing method |
| 03/22/2006 | CN1748741A Little leaf deervetch herb acne removing preparation and new preparing method |
| 03/22/2006 | CN1748735A Chinese herbal medicine composition and preparing method |
| 03/22/2006 | CN1748733A Throat powder formula for treating throat and oral diseases |
| 03/22/2006 | CN1748731A Compound preparation for cough and sputum and its preparing method |
| 03/22/2006 | CN1748730A Chinese medicine zhenhuang dripping pill and its preparing method |
| 03/22/2006 | CN1748728A Rabdosia dripping pill and its preparing method |
| 03/22/2006 | CN1748714A Method for preparing biological active substance of siphon-worm and its products |
| 03/22/2006 | CN1748700A Albendazole new form for treating nasal polyp and nasal polyp diseases |
| 03/22/2006 | CN1748699A Albendazole new form for treating allergic rhinitis |
| 03/22/2006 | CN1748698A Albendazole new form for treating chronic nasosinusitis |
| 03/22/2006 | CN1748697A Albendazole new form for treating chronic rhinitis |
| 03/22/2006 | CN1748696A Albendazole new form for treating adenoid hypertrophy |
| 03/22/2006 | CN1748695A Albendazole nasal jelly for treating nasal polyp and nasal polyp diseases |
| 03/22/2006 | CN1748694A Albendazole nasal jelly for treating allergic rhinitis |
| 03/22/2006 | CN1748693A Albendazole jelly for treating chronic nasosinusitis |
| 03/22/2006 | CN1748692A Albendazole jelly for treating chronic rhinitis |
| 03/22/2006 | CN1748691A Albendazole jelly for treating adenoid hypertrophy |
| 03/22/2006 | CN1748690A Oxibendazole new form for treating nasal polyp and nasal polyp diseases |
| 03/22/2006 | CN1748689A Oxibendazole newform for treating alllergic rhinitis |
| 03/22/2006 | CN1748688A Oxibendazole new form for treating chronic nasosinusitis |
| 03/22/2006 | CN1748687A Oxibendazole new form for treating chronic rhinitis |
| 03/22/2006 | CN1748686A Oxibendazole new form for treating adenoid hypertrophy |
| 03/22/2006 | CN1748685A Oxidendazole nasal jelly for treating nasal polyp and nasal polyp diseases |
| 03/22/2006 | CN1748684A Oxibendazole nasal jelly for treating allergic rhinitis |
| 03/22/2006 | CN1748683A Oxibendazole nasal jelly for treating chronic nasosinusitis |
| 03/22/2006 | CN1748682A Oxidenbazole nasal jelly for treating chronic rhinitis |
| 03/22/2006 | CN1748681A Oxibendazole nasal jelly for treating adenoid hypertrophy |
| 03/22/2006 | CN1748680A Medendazole new form for treating nasal polyp and nasal polyp disease |
| 03/22/2006 | CN1748679A Mebendazole new form for treating allergic rhinitis |
| 03/22/2006 | CN1748678A Medendazole new form for treating chronic nasosinusitis |
| 03/22/2006 | CN1748677A Mebendazole new form for treating chronic rhinitis |
| 03/22/2006 | CN1246447C Method for making health wine from fritillary bulb |
| 03/22/2006 | CN1246323C Nitrogen-based camptothecin derivatives |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246017C Medicine for treating asthma |